27 August, 2008

Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase ... - Forbes

NUTLEY, N.J., June 10 /PRNewswire/ -- Roche and Ipsen's investigational type 2 diabetes drug taspoglutide (R1583) has been shown to provide significant improvements in glucose control and...

Read More...